 condition has been stabilized. CEA should be

Ricotta et al e21

performed â±•2 weeks of the neurologic event (GRADE
1, Level of Evidence B).
3. Patients who present with repetitive (crescendo) episodes of transient cerebral ischemia unresponsive to
antiplatelet therapy should be considered for urgent
CEA. The risk of intervention is increased over elective
surgery for neurologic symptoms, but not as much as for
